UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy

Clinical genetics, 2020-06, Vol.97 (6), p.799-814

2020

Volltextzugriff (PDF)

Population-based incidence and prevalence of facioscapulohumeral dystrophy

Neurology, 2014-09, Vol.83 (12), p.1056-1059

2014

Volltextzugriff (PDF)

p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models

Nature genetics, 2021-08, Vol.53 (8), p.1207-1220

2021

Volltextzugriff (PDF)

MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4

Proceedings of the National Academy of Sciences - PNAS, 2013-12, Vol.110 (51), p.20783-20788

2013

Volltextzugriff (PDF)

Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice

Brain (London, England : 1878), 2012-04, Vol.135 (Pt 4), p.1081-1101

2012

Volltextzugriff (PDF)

Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy

Science (American Association for the Advancement of Science), 2010-09, Vol.329 (5999), p.1650-1653

2010

Volltextzugriff (PDF)

Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components

Gene therapy, 2020-05, Vol.27 (5), p.209-225

2020

Volltextzugriff (PDF)

Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene

PLoS genetics, 2010-10, Vol.6 (10), p.e1001181-e1001181

2010

Volltextzugriff (PDF)

DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle

Human molecular genetics, 2014-10, Vol.23 (20), p.5342-5352

2014

Volltextzugriff (PDF)

The FSHD2 Gene SMCHD1 Is a Modifier of Disease Severity in Families Affected by FSHD1

American journal of human genetics, 2013-10, Vol.93 (4), p.744-751

2013

Volltextzugriff (PDF)

DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis

PLoS genetics, 2013-11, Vol.9 (11), p.e1003947-e1003947

2013

Volltextzugriff (PDF)

Genetic and Epigenetic Characteristics of FSHD-Associated 4q and 10q D4Z4 that are Distinct from Non-4q/10q D4Z4 Homologs

Human mutation, 2014-08, Vol.35 (8), p.998-1010

2014

Volltextzugriff (PDF)

Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy

Neurology, 2020-06, Vol.94 (23), p.e2441

2020

Volltextzugriff (PDF)

DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy

PLoS genetics, 2017-03, Vol.13 (3), p.e1006658-e1006658

2017

Volltextzugriff (PDF)

Multiscale 3D-printing of microfluidic AFM cantilevers

Lab on a chip, 2020-01, Vol.2 (2), p.311-319

2020

Volltextzugriff (PDF)

Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation

Nucleic acids research, 2012-10, Vol.40 (18), p.9089-9101

2012

Volltextzugriff (PDF)

Genetic and epigenetic contributors to FSHD

Current opinion in genetics & development, 2015-08, Vol.33, p.56-61

2015

Volltextzugriff (PDF)

NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins

eLife, 2018-03, Vol.7

2018

Volltextzugriff (PDF)

snRNA-seq analysis in multinucleated myogenic FSHD cells identifies heterogeneous FSHD transcriptome signatures associated with embryonic-like program activation and oxidative stress-induced apoptosis

Human molecular genetics, 2024-01, Vol.33 (3), p.284-298

2024

Volltextzugriff (PDF)

Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers

Scientific reports, 2022-01, Vol.12 (1), p.1426-18, Article 1426

2022

Volltextzugriff (PDF)

Facioscapulohumeral muscular dystrophy

Muscle & nerve, 2006-07, Vol.34 (1), p.1-15

2006

Volltextzugriff (PDF)

A genome-wide signature of glucocorticoid receptor binding in neuronal PC12 cells

BMC neuroscience, 2012-10, Vol.13 (1), p.118-118, Article 118

2012

Volltextzugriff (PDF)

IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients

Journal of autoimmunity, 2017-02, Vol.77, p.104-115

2017

Volltextzugriff (PDF)

Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy

Muscle & nerve, 2020-05, Vol.61 (5), p.644-649

2020

Volltextzugriff (PDF)

Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis

Proceedings of the National Academy of Sciences - PNAS, 2021-03, Vol.118 (13)

2021

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(210)

Publikationsform

Sprache

Englisch
(239)

Erscheinungsjahr

n.n

Thema

Science & Technology
(199)
Humans
(178)
Life Sciences & Biomedicine
(178)
Muscular Dystrophy, Facioscapulohumeral - Genetics
(96)
Genetics & Heredity
(87)
Male
(77)
Female
(72)
Muscular Dystrophy
(69)
Biochemistry & Molecular Biology
(57)
Animals
(55)
Biological And Medical Sciences
(55)
Homeodomain Proteins - Genetics
(49)
Neurosciences & Neurology
(47)
Adult
(45)
Medical Sciences
(44)
Mutation
(43)
Middle Aged
(42)
Clinical Neurology
(40)
Neurology
(39)
Mice
(37)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy

Population-based incidence and prevalence of facioscapulohumeral dystrophy

p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models

MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4

Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice

Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy

Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components

Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene

DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle

The FSHD2 Gene SMCHD1 Is a Modifier of Disease Severity in Families Affected by FSHD1

DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis

Genetic and Epigenetic Characteristics of FSHD-Associated 4q and 10q D4Z4 that are Distinct from Non-4q/10q D4Z4 Homologs

Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy

DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy

Multiscale 3D-printing of microfluidic AFM cantilevers

Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation

Genetic and epigenetic contributors to FSHD

NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins

snRNA-seq analysis in multinucleated myogenic FSHD cells identifies heterogeneous FSHD transcriptome signatures associated with embryonic-like program activation and oxidative stress-induced apoptosis

Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers

Facioscapulohumeral muscular dystrophy

A genome-wide signature of glucocorticoid receptor binding in neuronal PC12 cells

IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients

Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy

Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis

Suchergebnisse filtern